scispace - formally typeset
J

Jane E. Visvader

Researcher at Walter and Eliza Hall Institute of Medical Research

Publications -  224
Citations -  32539

Jane E. Visvader is an academic researcher from Walter and Eliza Hall Institute of Medical Research. The author has contributed to research in topics: Stem cell & Cellular differentiation. The author has an hindex of 73, co-authored 215 publications receiving 29698 citations. Previous affiliations of Jane E. Visvader include Salk Institute for Biological Studies & University of Melbourne.

Papers
More filters
Journal ArticleDOI

Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

TL;DR: The cancer stem cell (CSC) hypothesis provides an attractive cellular mechanism to account for the therapeutic refractoriness and dormant behaviour exhibited by many of these tumours.
Journal ArticleDOI

Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells.

TL;DR: A workshop was convened by the AACR to discuss the rapidly emerging cancer stem cell model for tumor development and progression, and participants were charged with evaluating data suggesting that cancers develop from a small subset of cells with self-renewal properties analogous to organ regeneration.
Journal ArticleDOI

Generation of a functional mammary gland from a single stem cell

TL;DR: It is shown that a single cell, marked with a LacZ transgene, can reconstitute a complete mammary gland in vivo and establish that single cells within the Lin-CD29hiCD24+ population are multipotent and self-renewing, properties that define them as MaSCs.
Journal Article

Generation of a functional mammary gland from a single stem cell

TL;DR: In this article, the mammary gland can be functionally regenerated in mice by serial transplantation of epithelial fragments, providing evidence for the existence of self-renewing, multipotential mammary stem cells (MaSCs).
Journal ArticleDOI

Cells of origin in cancer

TL;DR: Evidence is also accumulating that cancers of distinct subtypes within an organ may derive from different 'cells of origin', and the identification of these crucial target cell populations may allow earlier detection of malignancies and better prediction of tumour behaviour.